GIMAP + Zonulin

Overwhelmingly, research indicates that gut health impacts overall health. The gut microbiome, in particular, plays a critical role in mediating the effects of diet and other factors on health, including digestive, immune, metabolic, and neuroendocrine functions. Assessing GI health with the proper tools can help practitioners get to the root cause of chronic illness.

The GI-MAP (Microbial Assay Plus) is unique in the field of comprehensive stool testing. It relies exclusively on quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi, and more, by targeting the specific DNA of the organisms tested.

The Gastrointestinal Microbial Assay Plus (GI-MAP) is an innovative clinical tool that measures gastrointestinal microbiota DNA from a single stool sample with state of the art, quantitative polymerase chain reaction (qPCR) technology.

The GI-MAP was designed to detect microbes that may be disturbing normal microbial balance or contributing to illness as well as indicators of digestion, absorption, inflammation, and immune function.

Almost every patient can benefit from a GI-MAP gut health assessment. Some patients are looking to achieve optimal health, while other patients have been chronically ill and frustrated without a diagnosis for years.

Some conditions that warrant testing are:

• Autoimmune diseases
• IBS/IBD
• Digestive complaints, diarrhea or constipation
• Brain fog
• Skin problems, like acne and psoriasis
• Mood disorders, depression, and anxiety
• Diabetes and weight loss issues

Collection instructions in English

Инструкции по сбору биоматериала на русском

Instructions de collecte en français